Update: CARB-X Grants Antabio Additional €4M to Develop Cystic Fibrosis Antibiotic
Update (03/01/2020): The global non-profit partnership CARB-X has awarded Antabio €4M ($4.4M) as a second…
03/01/2020 - 2 minutes
Infectious disease
Update: First Ever Ebola Vaccine Gets US and EU Approval
Update (20/12/2019): After getting conditional approval in Europe in November, Merck has received FDA approval…
20/12/2019 - 2 minutes
Danish Smallpox Vaccine Gets FDA Approval to Fight Bioterrorism
A vaccine developed by the Danish company Bavarian Nordic has received FDA approval to prevent…
25/09/2019 - 2 minutes
Themis Raises €40M for First Phase III Trial of a Chikungunya Vaccine
Vienna-based Themis Biosciences has raised €40M in a Series D round to fund a phase…
18/09/2019 - 3 minutes
Sepsis Diagnosed in 5 Minutes Instead of 24 Hours with Swiss Biotech’s Test
A test for sepsis developed by the Swiss diagnostics company Abionic was able to predict…
16/09/2019 - 3 minutes
Nabriva Therapeutics Gets FDA Green Light for Pneumonia Antibiotic
The US FDA has approved Nabriva Therapeutics’ Xenleta for treating community-acquired bacterial pneumonia, the first…
20/08/2019 - 3 minutes
First Potential Chlamydia Vaccine Shows Early Promise
A vaccine targeting the sexually transmitted infection chlamydia, which would be the first of its…
16/08/2019 - 3 minutes
Ultra-Fast Diagnostics Could Transform Sexual Health
Each day more than one million people around the world acquire sexually transmitted infections, with…
04/06/2019 - 7 minutes
European Biotechnology in 2019 and Beyond: What’s Hot and What’s Not?
We spend a lot of time focusing on specific developments in biotechnology, but sometimes it's…
25/04/2019 - 11 minutes
Flu Resistant to Antivirals? This Biotech Has a Drug for That
We are visiting the medieval German city of Tübingen this week. It hosts the biotech…
08/03/2019 - 3 minutes
Rapid Response mRNA Vaccine Facility Gets €30M Funding
An mRNA vaccine facility, run by the German biotech CureVac, has received a €30M development…
01/03/2019 - 3 minutes
Tuberculosis Treatment Kills Bacteria with Their Own Suicide Toxin
A European academic research collaboration has found a new potential weapon against antibiotic-resistant tuberculosis: its…
18/02/2019 - 3 minutes
